Sankala Group’s Biohaven BHVN Stock Holding History

Sankala Group’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.83K	Hold	204	–	–	﹤0.01%	492
2026 Q1	$1.77K	Hold	204	–	–	﹤0.01%	498
2025 Q4	$2.35K	Buy	+204	New	+$2.53K	﹤0.01%	487

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sankala Group's BHVN Position: Q2 2026 in Review

Sankala Group held its Biohaven (BHVN) position steady in Q2 2026 at 204 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Sankala Group first reported a position in BHVN in Q4 2025 and has held it in 3 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Sankala Group held 204 shares of Biohaven worth $2.83K as of Q2 2026.
Sankala Group left its Biohaven share count unchanged in Q2 2026.
Biohaven made up ﹤0.01% of Sankala Group's portfolio in Q2 2026, its #492 holding.
Sankala Group first reported a position in Biohaven in Q4 2025 and has held it in 3 quarters since.
296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.